Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

387 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

A Study to Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients With an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment

NCT05255133

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • GZA Antwerp, Belgium
  • AZ Rivierenland Bornem, Antwerp, Belgium
  • AZ Klina Brasschaat, Antwerp, Belgium
  • AZ Monica Deurne, Antwerp, Belgium
View Trial Details
Completed

Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the Liver

NCT02724540

Conditions
Liver Metastases, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Stanford University Standford, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Mount Sinai School of Medicine New York, United States
View all 13 locations
View Trial Details
Completed

Avelumab in G2-3 NET

NCT03278379

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • Sunnybrook Health Sciences Centre Toronto, Ontario, Canada
View Trial Details
Completed

United Kingdom (UK) Patient Preference Study of Somatuline Autogel and Treatment Administration Setting

NCT04649580

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
Locations
  • University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom
  • Cardiff and Vale University LHB Cardiff, United Kingdom
  • University Hospitals Coventry and Warwickshire NHS Trust Coventry, United Kingdom
  • Liverpool University Hospitals NHS Foundation Trust Liverpool, United Kingdom
View Trial Details
Completed

A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors

NCT03070301

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

NCT01794793

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +50 more
Locations
  • Ximed Research SC - SOM230B2412 La Jolla, California, United States
  • Cedars Sinai Medical Center Cedars Sinai 4 Los Angeles, California, United States
  • Stanford Universtiy Medical Center Stanford Hospital & Clinics Stanford, California, United States
  • University of Michigan Comprehensive Cancer Center SC-2 Ann Arbor, Michigan, United States
View all 94 locations
View Trial Details

Related conditions